For the study, researchers reviewed the anonymised medical records of 2,040 chelonia on the College's VetCompass database.
94.26% were recorded as tortoises, 3.63% terrapins and 2.11% turtles.
The most common tortoise species were Hermann’s tortoise, Horsfield’s tortoise and Mediterranean spur-thighed tortoise, while the most common terrapin species were musk turtle and yellow belly slider.
The study found that the most common disorders in tortoises were beak abnormality (17.68%), overgrown nails (11.91%) and shell abnormality (9.67%), while the most common disorders in terrapins were top and bottom shell abnormalities (13.51%).
The researchers say that most of these disorders are externally visible making them easier to recognise and diagnose, however they also often correspond with inappropriate husbandry and can be related to internal diseases that are harder to identify and diagnose.
The average age of death in the study was found to be 7.32 years, which is below the expected lifespan of most species of tortoise, suggesting that many are dying prematurely.
Dr Jessica May Hornby, exotic veterinary surgeon and lead author of the study, said:
“This research has provided us with a base to start to understand what veterinarians are currently seeing in practice and therefore give an insight into the health of the chelonian population.
"People are no longer only keeping the more common species of pets, such as dogs and cats, so this data is vital to understanding where and how owners and veterinarians need further support and training to ensure these brilliant little guys get the veterinary care they need, especially when many should easily be outliving us!”
Reference
Photo: www.depositphotos.com
The first is to confirm officially that Suprelorin, it's non-surgical alternative for neutering male dogs, may be implanted by RVNs under the direction of a veterinary surgeon under Schedule 3 of the Veterinary Surgeons Act.
The company is also hosting two free webinars for nurses to learn more about neutering: The Science of Canine Castration and Practical Tips for Clinics, presented by Dr Michelle Kutzler and Nicola Lakeman on Thursday 9th December 2021, and Behaviour in Post-Pandemic Puppies and Practical Tips for Clinics, presented by Stephanie Hedges and Nicola Lakeman on Thursday 16th December 2021.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "A huge surge in dog ownership in the last two years, combined with the additional pressures of Covid-19, has massively increased pressures on veterinary teams.
"At the same time we know that pet owner attitudes to surgical neutering is changing with 1 in 3 pet owners saying that they would look at alternative methods to surgical castration1.
"Suprelorin offers practices the opportunity to utilise the skills of their RVNs to provide a choice to clients when it comes to neutering and help to ease pressures on surgical waiting lists".
The Royal Veterinary College has announced the appointment of Professor Stuart Reid as its new Principal and the successor to Professor Quintin McKellar.
Professor Reid BVMS, PhD, DVM, DipECVPH, FRSE, MRCVS, joins the RVC from the University of Glasgow, where he was Professor of Veterinary Informatics and Epidemiology and Head of the School of Veterinary Medicine. He will take up his new role on 1st January 2011.
Professor Reid began his career in 1987 as an Assistant Veterinary Surgeon before joining the University of Glasgow as a Clinical Research Scholar in 1988. In 1992 he assumed the role of Post Doctoral Research Fellow at the University and was promoted to Senior Post-Doctoral Research Fellow in 1994. He was appointed to the first joint Chair between the Universities of Strathclyde and Glasgow in 1997, as Professor of Veterinary Informatics and Epidemiology. In 2004 he became Associate Dean of Research and, in 2005, he became Dean of the Faculty of Veterinary Medicine at the University of Glasgow.
"I am delighted and honoured to be joining the Royal Veterinary College at this important time." said Professor Reid. "The RVC has an enviable heritage and is a world leader in terms of its innovation and leadership in veterinary education, research and clinical service. I recognise that I am enormously privileged to be moving from a great School to a great College and I look forward to building on the successes achieved by RVC under Principal McKellar at the same time as rising to the challenges of a new funding environment."
Professor Quintin McKellar was appointed Principal in August 2004. He leaves the RVC to take the post of Vice-Chancellor of the University of Hertfordshire.
Chairman of the RVC Council, The Right Hon the Baroness Shephard of Northwold, said: "Great strides have been made under Professor McKellar's dynamic leadership, and I am sure I speak for all at the College when I say we will be sad to see him go. We look forward to welcoming Professor Stuart Reid, and firmly believe that his experience and distinguished academic record will assist the Royal Veterinary College in strengthening its position over the coming years."
Nick Stace, CEO of the Royal College of Veterinary Surgeons (RCVS), has issued a swift and robust response to the call by Unite for a shake up for the profession's regulatory system.
"Unite's suggestion that veterinary regulation should be under the scrutiny of the Professional Standards Authority (PSA) is misguided, because the PSA is there to oversee regulation in the human healthcare sector and the RCVS already has Department for Environment, Food and Rural Affairs (Defra) and Privy Council oversight.
"Its further thoughts around the RCVS disciplinary process are out of date and missing the point. We would be very happy to help put them right and to hear any legitimate concerns they may have.
"Unite is calling for the College to no longer 'set the rules and hand down judgments', when in fact last year we successfully achieved a Legislative Reform Order, backed by the profession, to ensure that our Disciplinary and Preliminary Investigation Committees will become independent from Council.
"Unite also talks about the profession's disquiet about last year's Disciplinary Hearing into Mr Chikosi, something we are well aware of and are currently responding to by looking at the biggest area of concern, the provision of 24/7 emergency cover. Our fact-finding mission is seeking views from the profession and the public.
"More broadly, though, feedback from our First Rate Regulator initiative has shown that the profession does have confidence in our disciplinary procedures and that they are certainly not subject to 'long-standing discontent'.
"The First Rate Regulator initiative is also leading to significant improvements in the way that complaints are handled, including speed to resolution.
"Unite is seeking to recruit members of the veterinary team as members of its union and it may be more successful in that pursuit if it was to start to understand the profession better, perhaps beginning with getting its facts right.
"We would be delighted to meet with Unite to put them right where they are factually wrong, and hear what they have to say."
The BVA has partnered with Closer Still Media, the impresarios behind the London Vet Show, to organise the event. They say it will cater for 1,500 veterinary professionals and provide high-value, low-cost, practical clinical and non-clinical CPD, big issue debates, and showcase key veterinary suppliers and vendors in the exhibition in a vibrant central location.
BVA President Daniella Dos Santos said: "I’m delighted to announce the launch of BVA Live. It’s an opportunity for BVA to return to hosting our own standalone conference for the first time since BVA Congress became part of the London Vet Show in 2013. The new conference will enable the veterinary community to come together, outside of London, to develop and thrive through a programme of excellent CPD, delivered by world class speakers.
"For me the most important element of BVA Live is bringing the veterinary profession together to tackle the big issues we face and providing an opportunity to engage with BVA Officers, volunteers and staff in one central venue. By hosting the conference at the NEC, Birmingham, with its excellent direct road, rail and air links it means that we can provide a greater regional offering to the veterinary profession."
It remains to be seen what impact this new conference will have on BSAVA Congress, which for many years was pretty much the only gig in town. Then, with the London Vet Show snapping at its heels, it announced it would move north from Birmingham to Manchester from 2021. Hardly will the dust have settled, than BVA and CloserStill are filling the void. At this rate, BSAVA Congress will probably have to move to the Hebrides by 2025.
It looks like there are a lot of dice being rolled here. Will more vets want to meet in Manchester than Birmingham? Will any of us be meeting next year, or will coronavirus continue to limit gatherings in 2021?
For more information and to register your interest in attending, visit bvalive.vetshow.com
The Livestock Adviser of the Year Award recognises those who have made a real difference to the operations of livestock farmers.
Julian focuses on dairy cow health and his particular interests include nutrition and benchmarking herd performance. Amongst other things, he has helped one large Dorset dairy farm reduce its antibiotic usage by two thirds over an eight year period.
Julian said: "I was honoured to be named Livestock Adviser of the Year. This work is my passion – I love working together with farmers, getting involved in all aspects of herd management and thinking through different options to improve herd health and productivity."
Runners up for the award were Phil Baynes, Managing Director of Baynes Nutrition, and Ed Hill, veterinary surgeon at Thrums Veterinary Group.
Friars Moor, Baynes Nutrition and Thrums Veterinary Group are all members of the XLVets community of independent veterinary practices.
Alice Renner, Farm Marketing Executive of XLVets, said: "We were so pleased to hear of these awards going to such hard-working and deserving people. And it’s a great accolade for our members – reflecting how XLVets practices strive for clinical excellence and really get invested in the success of their clients."
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
The veterinary group is stumping up more than £100,000 for the initiative, which will enable 20 vets and nurses, and 56 new grads from across the group to work with the Worldwide Veterinary Service (WVS) and other overseas animal charities.
The grants are for £1,500 and those taking part will also get up to one week of paid time off work whilst they volunteer.
VetPartners CEO Jo Malone said: “We wanted to support colleagues to have a fantastic experience while improving their skills in a different environment.
"It will give people a chance to use their clinical skills to give back to charities which are doing great work.
“If you’re working in a veterinary practice in Europe, you have support from team members around you and great facilities and equipment compared to the more challenging conditions working for a charity overseas.
"Working in these more challenging environments while they are volunteering will help build resilience, as our team members are unlikely to have experienced anything like this before.
“Charities like the World Veterinary Service are working ethically to help animals that may or may not have ever had veterinary care, and are doing a great job so we are delighted to support them.”
The Royal College of Veterinary Surgeons and British Small Animal Veterinary Association have issued a joint statement concerning the postgraduate qualifications CertAVP, PGCertSAM and PGCertSAS.
The statement follows the introduction earlier this year of the BSAVA's Postgraduate Certificates in Medicine and Surgery.
Dr Frances Barr, BSAVA's Director of Education (pictured right) said: "There has been a natural interest in how the BSAVA PGCertSAM and PGCertSAS compare with the RCVS Certificate in Advanced Veterinary Practice (CertAVP). Detailed discussions over the last few months between BSAVA and the RCVS have resulted in agreement that the two qualifications are academically equivalent, as outlined in a formal position statement. Individuals can therefore choose to study for the qualification which suits them best."
For thirty years, veterinary postgraduate qualifications at certificate level have been available within the UK; until recently, these were organised through and awarded by the RCVS. In recent years the Certificate in Advanced Veterinary Practice has been introduced, with assessment of accredited modules by a range of universities, and the final award made by the RCVS. With the development of the BSAVA Postgraduate Certificate programmes, questions have naturally arisen regarding the equivalence of these two programmes, and whether a stated requirement for 'a certificate' for a particular purpose refers to the general level of postgraduate qualification or to one particular qualification. It is natural that prospective candidates and employers should ask such questions when considering options for postgraduate study.
The joint position statement by the RCVS and the BSAVA:Representatives from the RCVS CertAVP subcommittee and BSAVA have therefore discussed the RCVS and BSAVA certificate programmes in detail. The statement here is intended to set out agreed principles which might be needed to allow resolution of any future questions about equivalence or accreditation.
The 'middle tier' postulated in the current RCVS Consultation on Specialisation, and the proposed 'acknowledged veterinarian' status under consideration in Europe, are not currently sufficiently defined to allow a position to be agreed.
The Education team will be talking to delegates about applying for 2013 places for the Postgraduate Certificates, its webinars and the new VN Merit Awards on the BSAVA Balcony at Congress from 11th-15th April.
Rodolfo said: “We are the only independent specialist veterinary hospital in the area with the equipment and experience to diagnose and manage neurological issues in pets.
"With a custom-built veterinary hospital and the expertise to help vets get the best results for their patients, we will provide the next level of affordable, specialist care for owners and their pets with the transparency that our independent status enables.
“We will work hand in hand with referring vets, consulting with them on the best approach for their clients and always keep them fully updated on progress as each case unfolds.
"Initially, we are offering neurology services, but we plan to quickly upscale our operations and offer other services like orthopaedics soon.”
Pets suffering from symptoms including seizures, pain, difficulty walking and problems with balance and orientation can be referred.
"Any peripheral nervous system problems and neuromuscular diseases outside the spinal cord area can also be identified and treated.
Rodolfo added: “My focus is on pure collaboration with the vets that refer to us and their owners.
"I’m wholeheartedly motivated by providing the very best service at accessible prices.
"With a focus on communication and compassion – we will always work with the first opinion vet to put the best interests of their clients’ pets first.
www.southeastvetreferrals.com
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
References
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."
A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health.
In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.
Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.
Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".
The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.
The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.
In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.
Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.
*ReferenceSchmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651
The BSAVA has announced that comic Michael McIntyre has joined the line up for Congress Party Night.
McIntyre will be joining comedian Fred MacAulay and ventriloquist Paul Zerdin
To register for BSAVA, click here.
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
Petplan has teamed up with Battersea Dogs & Cats Home to launch Summer Safety, a pet owner education campaign based on insurance claims received by the company.
The company reports that last year, 83% of all heat stroke claims occurred in the summer months (June-August), with 48% of them in July alone. Almost half of all heat stroke claims last year came in at an average of £315, with the highest claim reaching nearly £600.
80% of grass seed claims happened between June and August last year, 41% of which happened in July. The highest grass seed claim paid out by Petplan last year was just over £3,600, with the top ten highest grass seed claims totalling over £18,500.
Petplan says it also sees a significant spike in claims for injuries resulting from other foreign bodies in ears and paws in the summer months. Last year, 77% of claims arising from foreign bodies in ears and 55% for foreign bodies in paws occurred between June and August.
In order to alleviate the risk to pets and highlight the danger, Petplan and Battersea Dogs & Cats Home have created a guide to help pet owners determine how at-risk to heat their pet is. The guide is available to download at petplan.co.uk/summersafety and Battersea.org.uk/funinthesun.
Petplan's vet Brian Faulkner MRCVS said: "Using the simple four step process, the guide encourages pet owners to answer a series of questions that reveals their pet's SPF score, whilst including useful tips to help keep their pet out of harm's way during the hotter months. The scale calculates a pet's risk to retaining heat based on four factors, those being; coat colour, coat type, length of the animal's nose and its age, to determine either a low, medium or high risk susceptibility."
The CPD event takes place this Thursday 9th April, from 9:30am to 5:30pm, using the Zoom video conferencing platform. The organisers say that the agenda is still being finalised, but will be split into three streams: Farm Animal, Equine and Small Animal.
Confirmed speakers include:
Although the event is free, participants are asked make a voluntary contribution at justgiving.com/fundrasing/vets-for-nhs.
To register for the event, visit www.vetsfornhs.co.uk
Vets for NHS is supported by Boehringer Ingelheim, MSD Animal Health, Nimrod and the Scottish Vet Fair.
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Davies Veterinary Specialists (DVS) has announced that it has completed development work on its premises in Higham Gobion, Hertfordshire, to improve capacity and workflow for diagnostic procedures including MRI, CT and endoscopy.
The new development includes the construction and outfitting of an anaesthesia induction room with two state-of-the art stations, a diagnostic imaging viewing room, a further ultrasound and procedures room and office space for the nurse supervisor team. The rooms were built inside the site’s central barn as the next phase of DVS’s ongoing expansion programme, which has recently seen the completion of a new staff room and upgraded kennels and cattery facilities.
Clive Elwood, Managing Director of DVS said: “We first acquired the barn space in 2004 and initial construction included MRI and CT rooms with the plan of completing further rooms as needs arose. This latest development has already had a big impact on workflow and allows us to optimise the use of our diagnostic equipment. It represents our continued commitment to growth and development so that we can serve our customers to the best of our ability. I am very grateful to all of those who contributed to the project and showed necessary patience during construction.”
DVS now employs more than 35 specialist clinicians, 60 nurses, many with an advanced nursing qualification, and 30 administrators and support staff.
For further information visit www.vetspecialists.co.uk. You can also follow DVS on Facebook at http://www.facebook.com/DVSvets.
The offer is timed to coincide with the expected increase in canine pruritis as the warmer weather leads to increased levels of common allergens such as pollen, dust mites and flea bites.
Each practice that buys five packs of Apoquel will get one free, subject to a minimum qualifying purchase.
Apoquel is a fast-acting oral therapy for the treatment of canine pruritus associated with allergic dermatitis.
Zoetis says its novel mechanism of action on the Janus Kinase (JAK) enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
For more information about the Apoquel Spring offer, contact your Zoetis account manager.
The brainchild of Sonya Miles CertAVP(ZM), CertAqV, MRCVS, Just Exotic (www.justexotics.co.uk) offers a range of training webinars, fact sheets, care sheets and ‘how to’ videos developed for veterinary surgeons, nurses and students. The webinars cost between £15 and £55 (depending on the length), and include presentations by Sonya herself, Eliabetta Mancinelli, Agata Witkowska, Louise Ash, Sarah Pellett and others.
Sonya said: “We’ve developed our content to be convenient and affordable. Some of it may also be helpful for clients.
"More content will be added on a regular basis, and please, if there is something you specifically want covered, drop us a line to info@justexotics.co.uk and will we do our best to make sure it becomes available.”
The events will cover a range of subjects designed to boost morale, positively influence wellbeing and reduce the impact of seasonal affective disorder (SAD). They will also demonstrate how to support employees and colleagues to ensure work is sustainable, productive and enjoyable and guide veterinary professionals through mechanisms to make working life a more positive experience, despite the current climate.
The series will feature 30-minute presentations by wellbeing professionals such as sports psychiatrist, Dr Claire Gillvray (pictured right), human factors specialist, Dan Tipney, and occupational psychologist, Prof Elinor O’Connor.
The full programme is:
Liz Barton, co-founder of WellVet, said: “WellVet exists to provide practical tools and a supportive network to help positively influence and improve wellbeing and boost morale. This programme of events is designed to answer specific challenges we’re experiencing – now more than ever in veterinary teams, and to bring us together for a bit of festive cheer."
Emma McAnally, territory manager at Boehringer Ingelheim. said: “During these challenging times, work and life in general can often seem overwhelming. We are delighted to support the WellVet Winter Wellbeing series to help improve wellbeing both in the work and home environments.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
The programme, which starts in July, will cover a range of different exotic species, from initial examination and diagnostic sample collection to anaesthesia, surgery, and diagnostic imaging. It will also cover the workup and treatment of common diseases seen in these species.
Delegates can opt to attend three practical attendance modules which will cover small mammal surgery, avian surgery and endoscopy.
Course Director Simon Girling BVMS (Hons) DZooMed, DipECZM (ZHM), CBiol, FRSB, EurProBiol, FRCVS RCVS Recognised Specialist in Zoo and Wildlife Medicines, said: “Exotic Animal medicine is a rapidly changing discipline with new information and a greater understanding of individual species' needs growing with each passing day. The programme aims to give the delegate an in-depth view of the current best practice in exotic animal medicine and surgery and is directly relevant to the day-to-day work of the veterinary surgeon in clinical practice.
“Our expert Module Tutors, including Charly Pignon DVM Dipl. ECZM, Richard A Saunders BSc (Hons) BVSc FRSB CBiol DZooMed (Mammalian) DipECZM (ZHM) MRCVS RCVS Specialist in Zoo and Wildlife Medicine (Mammalian) European Specialist in Zoological Medicine (ZHM) and Stephen Divers BVetMed, DZooMed, DECZM(Herp) DECZM(ZHM) DACZM FRCVS, will provide support during every module.”
David Babington MRCVS, Business Development Director at Improve International, added: “We know that the prospect of treating exotic patients can fill veterinary surgeons with dread. Taking this course will increase their confidence by building their knowledge of the fundamentals of exotic animal medicine and surgery. In doing so, they will also be able to take more informed clinical approach to treating these patients.”
The programme offers a route to achieve academic qualifications - the General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with ISVPS and Harper Adams University. Gaining a PgC enables delegates to apply to the RCVS for Advanced Practitioner Status in the subject.
For further information and to register interest visit: https://www.improveinternational.com/uk/course/exotic-animal-practice-distance-learning/
You can also watch a video in which Simon Girling introduces the course: https://www.youtube.com/watch?v=6NoRy4ZK5Dw
Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.